Document is current
Any future updates will be listed below
-
Authors
Sällström, Torsten https://orcid.org/0009-0001-4818-2531
Bärebring, Linnea https://orcid.org/0000-0002-1612-1697
Hulander, Erik https://orcid.org/0000-0003-3416-2748
Gjertsson, Inger https://orcid.org/0000-0002-9301-4844
Winkvist, Anna https://orcid.org/0000-0001-9122-7240
Lindqvist, Helen M. https://orcid.org/0000-0002-2627-0434
-
Funding
Funding for this research was provided by:
Vetenskapsrådet (2021-00954, 2021-00954)
Magnus Bergvalls Foundation (2019-03320)
Swedish government under the ALF agreement (ALFGBG-716341)
University of Gothenburg
- License Information
-
More Information
Article History
Received: 29 January 2024
Accepted: 27 March 2025
First Online: 11 April 2025
Declarations
:
: This study complies with the Declaration of Helsinki. The PIRA trial is registered at Clinicaltrials.gov (NCT04247009) and was approved by the Swedish Ethical Review Authority (Dnr. 2019–05242). All participants voluntarily signed written informed consent forms.
: Not applicable.
: The authors declare no competing interests.
